Literature DB >> 26339404

Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.

Chunlei He1, Hui Gao1, Xiaona Fan2, Maoyuan Wang1, Wuyang Liu1, Weiming Huang1, Yadong Yang1.   

Abstract

Osteosarcoma remains a leading cause of cancer death in children and young adolescents. Although the introduction of multiagent chemotherapy, survival rates have not improved in two decades. Therefore, it is urgently needed to know the details regarding molecular etiology to driving therapeutic inroads for this disease. In this study we performed an integrated analysis of miRNA and mRNA expression data to explore the dysregulation of miRNA and miRNA-target gene regulatory network underlying OS. 59 differentially expressed miRNAs were identified, with 28 up-regulated and 31 down-regulated miRNAs by integrating OS miRNA expression data sets available. Using miRWalk databases prediction, we performed an anticorrelated analysis of miRNA and genes expression identified by a integrated analysis of gene expression data to identify 109 differently expressed miRNA target genes. A novel miRNA-target gene regulatory network was constructed with the miRNA-target gene pairs. miR-19b-3p, miR-20a-5p, miR-124-3p and their common target CCND2, the nodal points of regulatory network, may play important roles in OS. Bioinformatics analysis of biological functions and pathways demonstrated that target genes of miRNAs are highly correlated with carcinogenesis. Our findings may help to understand the molecular mechanisms of OS and identify targets of effective targeted therapies for OS.

Entities:  

Keywords:  Integrated analysis; miRNA expression data; miRNA target genes; osteosarcoma

Mesh:

Substances:

Year:  2015        PMID: 26339404      PMCID: PMC4555732     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  38 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  miRNA-646 suppresses osteosarcoma cell metastasis by downregulating fibroblast growth factor 2 (FGF2).

Authors:  Xiao-hui Sun; Xiao-lin Geng; Jun Zhang; Chao Zhang
Journal:  Tumour Biol       Date:  2014-11-18

3.  MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma.

Authors:  Daniel Baumhoer; Stephanie Zillmer; Kristian Unger; Michael Rosemann; Michael J Atkinson; Martin Irmler; Johannes Beckers; Heide Siggelkow; Irene von Luettichau; Gernot Jundt; Jan Smida; Michaela Nathrath
Journal:  Cancer Genet       Date:  2012-05

4.  MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1.

Authors:  Stuart Hunt; Adam V Jones; Emma E Hinsley; Simon A Whawell; Daniel W Lambert
Journal:  FEBS Lett       Date:  2010-11-27       Impact factor: 4.124

5.  Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.

Authors:  Hongping Xia; William K C Cheung; Samuel S Ng; Xiaochun Jiang; Songshan Jiang; Johnny Sze; Gilberto K K Leung; Gang Lu; Danny T M Chan; Xiu-Wu Bian; Hsiang-fu Kung; Wai Sang Poon; Marie C Lin
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

6.  miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Authors:  Kevin B Jones; Zaidoun Salah; Sara Del Mare; Marco Galasso; Eugenio Gaudio; Gerard J Nuovo; Francesca Lovat; Kimberly LeBlanc; Jeff Palatini; R Lor Randall; Stefano Volinia; Gary S Stein; Carlo M Croce; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

7.  Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.

Authors:  Riccardo Di Fiore; Daniele Fanale; Rosa Drago-Ferrante; Ferdinando Chiaradonna; Michela Giuliano; Anna De Blasio; Valeria Amodeo; Lidia R Corsini; Viviana Bazan; Giovanni Tesoriere; Renza Vento; Antonio Russo
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

8.  Solid tumors of childhood display specific serum microRNA profiles.

Authors:  Matthew J Murray; Katie L Raby; Harpreet K Saini; Shivani Bailey; Sophie V Wool; Jane M Tunnacliffe; Anton J Enright; James C Nicholson; Nicholas Coleman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-21       Impact factor: 4.254

9.  miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors.

Authors:  Espen Enerly; Israel Steinfeld; Kristine Kleivi; Suvi-Katri Leivonen; Miriam R Aure; Hege G Russnes; Jo Anders Rønneberg; Hilde Johnsen; Roy Navon; Einar Rødland; Rami Mäkelä; Bjørn Naume; Merja Perälä; Olli Kallioniemi; Vessela N Kristensen; Zohar Yakhini; Anne-Lise Børresen-Dale
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

10.  Identification of Differentially Expressed MicroRNAs in Osteosarcoma.

Authors:  Rishi R Lulla; Fabricio F Costa; Jared M Bischof; Pauline M Chou; Maria de F Bonaldo; Elio F Vanin; Marcelo B Soares
Journal:  Sarcoma       Date:  2011-07-18
View more
  6 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion.

Authors:  Yi-Xin Du; Lin-Xin Guo; Han-Song Pan; Yi-Min Liang; Xiang Li
Journal:  Hum Cell       Date:  2019-10-30       Impact factor: 4.174

3.  A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer.

Authors:  Peide Huang; Fengyu Li; Zongchao Mo; Chunyu Geng; Fang Wen; Chunyan Zhang; Jia Guo; Song Wu; Lin Li; Nils Brünner; Jan Stenvang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

4.  The TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma.

Authors:  Jianjun Ma; Kangmao Huang; Yan Ma; Menglu Zhou; Shunwu Fan
Journal:  Cell Death Dis       Date:  2017-01-05       Impact factor: 8.469

5.  PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.

Authors:  A K Hoyt; A Moran; C Granger; A Sedani; S Saigh; J Brown; K A Galoian
Journal:  Oncol Rep       Date:  2019-05-24       Impact factor: 3.906

6.  miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN.

Authors:  Ming He; Peng Shen; Chuang Qiu; Jiashi Wang
Journal:  Aging (Albany NY)       Date:  2019-08-14       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.